| Atypical parkinsonism and cerebrotendinous xanthomatosis: Report of a family with corticobasal syndrome and a literature review. | |
| | |
MedLine Citation:
|
PMID: 23124517 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Cerebrotendinous xanthomatosis is an autosomal recessive inborn error of cholesterol metabolism. It presents with systemic and neurological symptoms, rarely including parkinsonism. Presented here are a clinical description of a new family with cerebrotendinous xanthomatosis and parkinsonism and a review of 13 additional cases reported in the literature. The index case developed corticobasal syndrome, previously not reported in cerebrotendinous xanthomatosis. His brother had parkinsonism with cerebellar features and cognitive impairment. In a literature review, median age of onset of parkinsonism was found to be 40 years. Nearly all patients had other neurological symptoms: cognitive (93%), pyramidal (93%), or cerebellar (53%). All patients had walking difficulties, with falls in 27%. Systemic features were common: cataracts (93%) or tendon xanthomata (87%). Frequent MRI abnormalities included cerebellar atrophy (100%), cerebral atrophy (80%), and dentate nuclei signal changes (80%). Functional dopaminergic imaging often demonstrated presynaptic denervation. Improvement with levodopa was frequent (91%) but mild. Progressive neurological decline occurred in 92% of patients despite treatment with chenodeoxycholic acid. Cerebrotendinous xanthomatosis should be considered in the differential diagnosis of atypical parkinsonism, including corticobasal syndrome, particularly with early age of onset and in the context of a complex neurological phenotype. Tendon xanthomata, early-onset cataracts, and radiological findings of cerebellar atrophy with lesions of the dentate nuclei are useful clinical clues. Symptomatic treatment with levodopa may help, but progressive neurological decline is frequent despite treatment with chenodeoxycholic acid. © 2012 Movement Disorder Society. |
| | |
Authors:
|
Ignacio Rubio-Agusti; Maja Kojovic; Mark J Edwards; Elaine Murphy; Hoskote S Chandrashekar; Robin H Lachmann; Kailash P Bhatia |
Related Documents
:
|
7377677 - Heterotopic gastric epithelium in the head and neck region. 10498367 - Methemoglobinemia secondary to topical silver nitrate therapy--a case report. 15372917 - Brown recluse spider bites to the head: three cases and a review. 12451377 - Benign cephalic histiocytosis: a case report and review. 17785907 - Vertical transmission of salmonella paratyphi a. 9716637 - Spondyloenchondrodysplasia: several phenotypes--the same syndrome. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-2 |
Journal Detail:
|
Title: Movement disorders : official journal of the Movement Disorder Society Volume: - ISSN: 1531-8257 ISO Abbreviation: Mov. Disord. Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8610688 Medline TA: Mov Disord Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Movement Disorder Society. |
Affiliation:
|
Sobell Department for Movement Disorders and Motor Neuroscience, UCL Institute of Neurology, London, United Kingdom; Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom; Movement Disorders Unit, Department of Neurology, Hospital Universitari La Fe, Valencia, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The utilization of carotid artery imaging beyond metabolic scores and high-sensitivity CRP in screen...
Next Document: Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL.